The Valley Desk

Clinical trial reportThe New England journal of medicinePublished

Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Sidney Kimmel Medical College, Thomas Jefferson University. Affiliation source

Publication record

Type
Clinical trial report
Venue
The New England journal of medicine
Published
Subject terms
Humans; Carcinoma, Neuroendocrine; Thyroid Neoplasms; Disease Progression; Anilides; Piperidines; Pyrazoles; Pyridines; Quinazolines; Antineoplastic Agents; Proto-Oncogene Proteins c-ret
PubMed ID
37870969
Added to directory
Source checked

Report a correction or request removal